Edition:
India

Cegedim SA (CGDM.PA)

CGDM.PA on Paris Stock Exchange

24.95EUR
15 Jul 2019
Change (% chg)

€-0.05 (-0.20%)
Prev Close
€25.00
Open
€26.00
Day's High
€26.00
Day's Low
€24.90
Volume
5,309
Avg. Vol
3,081
52-wk High
€33.90
52-wk Low
€19.00

Latest Key Developments (Source: Significant Developments)

Cegedim Q1 Revenue Up At 119.2 Million Euros
Wednesday, 15 May 2019 

May 15 (Reuters) - CEGEDIM SA ::Q1 REVENUE EUR 119.2 MILLION VERSUS EUR 111.9 MILLION YEAR AGO.PLANS AN ORGANIC GROWTH OF 5% FOR REVENUE AND AN EBITDA GROWTH OF 5%.  Full Article

Cegedim FY EBITDA Down At 76.8 Million Euros
Wednesday, 27 Mar 2019 

March 27 (Reuters) - CEGEDIM SA ::CEGEDIM: DEBT REDUCTION AND REVENUE GROWTH IN 2018.FY EBITDA EUR 76.8 MILLION VERSUS EUR 77.5 MILLION YEAR AGO.FY REVENUE EUR 467.7 MILLION VERSUS EUR 457.4 MILLION YEAR AGO.FY NET PROFIT ATTRIBUTABLE TO OWNERS OF PARENT EUR 5.8 MILLION VERSUS EUR 11.1 MILLION YEAR AGO.THE GROUP HAS SET A TARGET OF AROUND 5% GROWTH IN BOTH LIKE-FOR-LIKE REVENUES AND EBITDA.IN 2019, THE GROUP DOES NOT EXPECT ANY SIGNIFICANT ACQUISITIONS AND IS NOT ISSUING ANY EARNINGS ESTIMATES OR FORECASTS.IN 2018 NET DEBT CUT BY EUR 128.2 MILLION.OPERATING FREE CASH FLOW WAS A POSITIVE €64.8 MILLION FOR FINANCIAL YEAR 2018 COMPARED WITH A POSITIVE €13.4 MILLION IN 2017.2019 TARGET: 5% REVENUE AND EBITDA GROWTH.  Full Article

Cegedim Announces Partnership Between Docavenue And RDV Medicaux
Wednesday, 10 Oct 2018 

Oct 11 (Reuters) - CEGEDIM SA ::ANNOUNCED ON WEDNESDAY PARTNERSHIP BETWEEN DOCAVENUE, START-UP OF CEGEDIM, WITH RDV MEDICAUX .PARTNERSHIP AIMS TO BRING PATIENTS CLOSER TO HEALTHCARE PROFESSIONALS.DOCAVENUE AND RDV MEDICAL TO OPEN RECIPROCAL ACCESS TO THEIR REFERENCED PRACTITIONERS TO FACILITATE APPOINTMENT BOOKING FROM ONE PLATFORM TO THE OTHER.  Full Article

Cegedim EBITDA Margin Improved In The First Half Of 2018
Monday, 17 Sep 2018 

Sept 17 (Reuters) - Cegedim SA ::CEGEDIM: EBITDA MARGIN IMPROVED IN THE FIRST HALF OF 2018.  Full Article

Cegedim H1 EBITDA Up At 33.3 Million Euros
Monday, 17 Sep 2018 

Sept 17 (Reuters) - CEGEDIM SA ::H1 EBITDA EUR ‍​33.3 MILLION VERSUS EUR 29.8 MILLION YEAR AGO.MOST FULL-YEAR MARGIN IMPROVEMENT TO HAVE TAKEN PLACE IN H1 2018.FOR 2018, SEES MODEST LIKE-FOR-LIKE REVENUE AND EBITDA MARGIN GROWTH.H1 CONSOLIDATED NET LOSS FROM CONTINUING ACTIVITIES EUR 0.7 MILLION VERSUS LOSS OF EUR 6.1 MILLION YEAR AGO.DOES NOT ISSUE ANY EARNINGS ESTIMATES OR FORECASTS.  Full Article

Cegedim Q1 Revenue Up At 111.9 Million Euros
Thursday, 26 Apr 2018 

April 26 (Reuters) - CEGEDIM SA ::Q1 REVENUE EUR 111.9 MILLION VERSUS EUR 110.0 MILLION YEAR AGO.CAUTIOUSLY OPTIMISTIC FOR 2018.BREXIT IS UNLIKELY TO HAVE A MATERIAL IMPACT ON GROUP EBIT..  Full Article

Bpifrance Announces Sale Of Its Cegedim's Shares, For 9 To 12 Percent Of Capital
Monday, 12 Feb 2018 

Feb 12 (Reuters) - Bpifrance: :SALE OF CEGEDIM SA<<>> SHARES HELD BY BPIFRANCE FOR 9% TO 12% OF CAPITAL .SHARES HELD BY BPIFRANCE FOR 9% TO 12% OF CAPITAL .FREE-FLOAT TO INCREASE TO REACH MAX OF 44.1% OF CAPITAL - BPI FRANCE.FOLLOWING SETTLEMENT, BPIFRANCE PARTICIPATIONS WILL SELL A MAXIMUM OF 12% OF CEGEDIM’S CAPITAL .THEREFORE, BPIFRANCE PARTICIPATIONS WILL POTENTIALLY BREACH DOWNWARDS 5% THRESHOLD.  Full Article

Cegedim Q4 Consolidated Revenue Up 6.3 Percent At 126.5 Million Euros
Monday, 29 Jan 2018 

Jan 29 (Reuters) - Cegedim Sa ::OUTLOOK FOR CONSOLIDATED 2017 EBITDA RAISED SIGNIFICANTLY.NOW EXPECTS 2017 EBITDA FROM CONTINUING ACTIVITIES TO EXCEED EUR 72 MILLION..CONSOLIDATED Q4 2017 REVENUES FROM CONTINUING ACTIVITIES OF EUR 126.5 MILLION, UP 6.3% ON A REPORTED BASIS.  Full Article

Cegedim ‍Sells Cegelease Business to Société Générale​
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - CEGEDIM SA ::‍SALE OF CEGELEASE BUSINESS​.DEAL IS EXPECTED TO CLOSE DURING Q1 OF 2018.GROUP IS NOT PLANNING ANY OTHER DIVESTMENT.SIGNS A SALES AGREEMENT WITH SOCIÉTÉ GÉNÉRALE.SALE PRICE IS EUR 57.5 MILLION, PLUS REIMBURSEMENT OF SHAREHOLDER'S LOAN ACCOUNT, WHICH AMOUNTED TO EUR 13 MILLION ON JUNE 30..WILL USE EUR 30 MILLION TO PAY DOWN ITS DEBT.  Full Article